Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06632730 · ClinicalTrials.gov registry record

Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

A clinical trial, sponsored by Novartis.

Completed
Registry status
69
Enrollment target

NCT06632730 is a clinical trial that has completed, run by Novartis. The registered enrollment target is 69 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06632730 has completed, sponsored by Novartis.

COMPLETED
Registry status
69 participants
Enrollment target

Study Summary

An observational, retrospective, cross-sectional, multicenter study. Real-world data were obtained from medical records of Spanish public hospitals (9 hospitals).

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2023-07-05
Est. Completion 2023-11-20

Sponsor

Novartis

265 total trials

What the Registry Record Tells You About NCT06632730

The ClinicalTrials.gov registry entry for NCT06632730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT06632730 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06632730 about?

NCT06632730 is a clinical study titled "Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain". An observational, retrospective, cross-sectional, multicenter study. Real-world data were obtained from medical records of Spanish public hospitals (9 hospitals).

What is the current status of trial NCT06632730?

This trial is currently completed. The enrollment target is 69 participants. The study started on 2023-07-05. Estimated completion is 2023-11-20.

Who is sponsoring clinical trial NCT06632730?

This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.